Abstract:This review comprehensively summarizes the advances in research for fibrosis. It emphasizes organ‐specific profibrotic cell types and molecular mechanisms of fibrosis, especially in the kidney, liver, lung, and heart. The authors highlight the advanced antifibrotic small molecule drugs and cellular therapies for fibrosis. These findings have critical implications for further research and clinical translation of medicine. As the final stage of disease‐related tissue injury and repair, fibrosis is characterized by excessive accumulation of the extracellular matrix. Unrestricted accumulation of stromal cells and matrix during fibrosis impairs the structure and function of organs, ultimately leading to organ failure. The major etiology of fibrosis is an injury caused by genetic heterogeneity, trauma, virus infection, alcohol, mechanical stimuli, and drug. Persistent abnormal activation of "quiescent" fibroblasts that interact with or do not interact with the immune system via complicated signaling cascades, in which parenchymal cells are also triggered, is identified as the main mechanism involved in the initiation and progression of fibrosis. Although the mechanisms of fibrosis are still largely unknown, multiple therapeutic strategies targeting identified molecular mechanisms have greatly attenuated fibrotic lesions in clinical trials. In this review, the organ‐specific molecular mechanisms of fibrosis is systematically summarized, including cardiac fibrosis, hepatic fibrosis, renal fibrosis, and pulmonary fibrosis. Some important signaling pathways associated with fibrosis are also introduced. Finally, the current antifibrotic strategies based on therapeutic targets and clinical trials are discussed. A comprehensive interpretation of the current mechanisms and therapeutic strategies targeting fibrosis will provide the fundamental theoretical basis not only for fibrosis but also for the development of antifibrotic therapies.

Telocytes in Fibrosis Diseases: From Current Findings to Future Clinical Perspectives

Telocytes in Human Liver Fibrosis.

Tangled Fibroblasts in Tumor‐stroma Interactions

Telocytes In Regenerative Medicine

Hepatic Telocytes.

Roles of Telocytes Dominated Cell–cell Communication in Fibroproliferative Acute Respiratory Distress Syndrome

Roles of telocytes dominated cell-cell communication in fibroproliferative acute respiratory distress syndrome

Telocytes In Liver Regeneration: Possible Roles

Telocyte Morphologies and Potential Roles in Diseases

Telocytes and Lung Disease.

Telocytes in Liver: Electron Microscopic and Immunofluorescent Evidence

Telocytes: current methods of research, challenges and future perspectives

Potential Roles of Telocytes in Lung Diseases

Cardiac Telocytes and Fibroblasts in Primary Culture: Different Morphologies and Immunophenotypes

The History of Telocyte Discovery and Understanding.

Crosstalk between fibroblasts and immunocytes in fibrosis: From molecular mechanisms to clinical trials

CXCL12/CXCR4: an amazing challenge and opportunity in the fight against fibrosis

Targeting Fibrosis: From Molecular Mechanisms to Advanced Therapies

Transforming growth factor-β signaling: From tissue fibrosis to therapeutic opportunities

Transforming growth factor- signaling: From tissue fibrosis to therapeutic opportunities

Genetic Comparison of Mouse Lung Telocytes with Mesenchymal Stem Cells and Fibroblasts